Rubric Capital Management LP
Heron Therapeutics, Inc. · 10% Owner
Rubric Capital Management LP is listed in filings as 10% Owner at Heron Therapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 17, 2025, including sale activity and purchase activity. Recent filings connect the profile to Heron Therapeutics, Inc. (HRTX), Collegium Pharmaceutical, Inc. (COLL), Talen Energy Corporation (TLN), and Mereo BioPharma Group plc (MREO). The current snapshot covers public activity from Jun 17, 2024 to Oct 17, 2025. Reported amounts are shown as $946.3K to $22.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.